Income · Stocks to Consider and Updates

J&J to Acquire Taris Biomedical and Completes Stake in Verb Surgical

Health care giant Johnson & Johnson (NYSE: JNJ - $146.06) said it is acquiring Taris Biomedical LLC, a privately owned biotech company focusing on a drug-delivery device for the treatment of bladder diseases, including cancer. The silicone delivery device allows for the continued release of medication into the bladder, the company said. Taris will become… Continue reading J&J to Acquire Taris Biomedical and Completes Stake in Verb Surgical

Income · Stocks to Consider and Updates

Allocation Update – Income Portfolio

As I posted yesterday in the conservative portfolio update, I am also makings a few minor changes to the income candidate list to better reflect what I see as opportunities and headwinds in 2020. While the portfolio itself remains unchanged, I am tweaking the percentage allocations as follows: On the plus side is CVS Health,… Continue reading Allocation Update – Income Portfolio

Income · Stocks to Consider and Updates

Cisco Beats Estimates; Outlook Disappoints

Networking equipment and software maker Cisco Systems (NASDAQ: CSCO - $44.91) reported mixed results for the fiscal first quarter and provided a cautious outlook on its operating environment, causing the shares to decline about 7% in early trading. Revenue came in at of $13.2 billion, up 1% from a year ago, slightly ahead of analysts’… Continue reading Cisco Beats Estimates; Outlook Disappoints

Income · Stocks to Consider and Updates

CVS Posts Strong Results; Raises Guidance

Woonsocket, Rhode Island-based CVS Health (NYSE: CVS - $70.56) reported a stronger-than-expected adjusted profit in the third quarter and raised its outlook for earnings. The company reported net income of $1.53 billion compared with $1.39 billion a year ago. Excluding certain items, CVS posted an adjusted profit of $1.84 a share compared to an adjusted $1.73… Continue reading CVS Posts Strong Results; Raises Guidance

Income · Stocks to Consider and Updates

LyondellBasell Misses Forecasts; Outlook Positive

Chemical and oil refining giant LyondellBasell Industries (NYSE: LYB - $96.78) announced net income for the third quarter of $1.0 billion, equal to an adjusted $2.70 per share vs. $2.96 a year ago. Integration activities related to the acquisition of A. Schulman are on schedule and expected to generate approximately $125 million in forward annual run-rate synergies as… Continue reading LyondellBasell Misses Forecasts; Outlook Positive

Income · Stocks to Consider and Updates

Total Beats Estimates; Hikes Dividend

French energy giant Total SA (NYSE: TOT- $52.70) reported a slump in third-quarter earnings due to a plunge in oil and natural gas prices but a surge in production in the period helped beat sales and profit forecasts. Revenue from sales at the Paris-based company dropped to $42.54 billion for the period from $48.4 billion a year ago but was… Continue reading Total Beats Estimates; Hikes Dividend

Conservative · Income · Stocks to Consider and Updates

Verizon Delivers In-Line Results; Inks Deal with Disney

Verizon Communications, Inc. (NYSE: VZ - $60.20) reported third quarter earnings of $1.25 a share, a penny above estimates and a modest 2% higher than a year-ago, on a 1% top-line improvement. Beginning in the June quarter, Verizon started reporting financial and operational results under its new operational structure: Consumer and Business.        Total Verizon… Continue reading Verizon Delivers In-Line Results; Inks Deal with Disney